"Novo Nordisk's Ozempic and Wegovy, long in shortage, are now listed as available by FDA
It remains unclear how the update could affect patients as well as compounders
All doses of Novo Nordisk's blockbuster diabetes and obesity treatments are listed as available on the Food and Drug Administration's drug shortage list as of Wednesday, raising the possibility that the medications could soon be taken off the list entirely, a development that could affect compounding pharmacies and patients relying on compounded drugs".
StatNews:
https://www.statnews.com/2024/10/30/novo-nordisk-ozempic-wegovy-fda-available-or-in-shortage/
It remains unclear how the update could affect patients as well as compounders
All doses of Novo Nordisk's blockbuster diabetes and obesity treatments are listed as available on the Food and Drug Administration's drug shortage list as of Wednesday, raising the possibility that the medications could soon be taken off the list entirely, a development that could affect compounding pharmacies and patients relying on compounded drugs".
StatNews:
https://www.statnews.com/2024/10/30/novo-nordisk-ozempic-wegovy-fda-available-or-in-shortage/
